Literature DB >> 24096015

In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer.

Nunzio Denora1, Valentino Laquintana, Antonio Lopalco, Rosa Maria Iacobazzi, Angela Lopedota, Annalisa Cutrignelli, Giuliano Iacobellis, Cosimo Annese, Mariafrancesca Cascione, Stefano Leporatti, Massimo Franco.   

Abstract

Mitochondria represent an attractive subcellular target due to its function particularly important for oxidative damage, calcium metabolism and apoptosis. However, the concept of mitochondrial targeting has been a neglected area so far. The translocator protein (TSPO) represents an interesting subcellular target not only to image disease states overexpressing this protein, but also for a selective mitochondrial drug targeting. Recently, we have delivered in vitro and in vivo small molecule imaging agents into cells overexpressing TSPO by using a family of high-affinity conjugable ligands characterized by 2-phenyl-imidazo[1,2-a]pyridine acetamide structure. As an extension, in the present work we studied the possibility to target and image TSPO with dendrimers. These nano-platforms have unique features, in fact, are prepared with a level of control not reachable with most linear polymers, leading to nearly monodisperse, globular macromolecules with a large number of peripheral groups. As a consequence, they are an ideal delivery vehicle candidate for explicit study of the effects of polymer size, charge, composition, and architecture on biologically relevant properties such as lipid bilayer interactions, cytotoxicity, cellular internalization, and subcellular compartments and organelles interactions. Here, we present the synthesis, characterization, cellular internalization, and mitochondria labeling of a TSPO targeted fourth generation [G(4)-PAMAM] dendrimer nanoparticle labeled with the organic fluorescent dye fluorescein. We comprehensively studied the cellular uptake behavior of these dendrimers, into glioma C6 cell line, under the influence of various endocytosis inhibitors. We found that TSPO targeted-G(4)-PAMAM-FITC dendrimer is quickly taken up by these cells by endocytosis pathways, and moreover specifically targets the mitochondria as evidenced from subcellular fractionation experiments and co-localization studies performed with CAT (Confocal-AFM-TIRF) microscopy.
© 2013.

Entities:  

Keywords:  Confocal microscopy; Imaging; PAMAM dendrimer; Subcellular fractionation; Subcellular targeting; TSPO

Mesh:

Substances:

Year:  2013        PMID: 24096015     DOI: 10.1016/j.jconrel.2013.09.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.

Authors:  Pengkai Ma; Huajun Yu; Xuemei Zhang; Hongjie Mu; Yongchao Chu; Ling Ni; Pingping Xing; Yiyun Wang; Kaoxiang Sun
Journal:  Pharm Res       Date:  2016-11-15       Impact factor: 4.200

2.  Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand.

Authors:  Nunzio Denora; Nicola Margiotta; Valentino Laquintana; Angela Lopedota; Annalisa Cutrignelli; Maurizio Losacco; Massimo Franco; Giovanni Natile
Journal:  ACS Med Chem Lett       Date:  2014-03-30       Impact factor: 4.345

3.  Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast.

Authors:  Antonio Lopalco; Hazem Ali; Nunzio Denora; Erik Rytting
Journal:  Int J Nanomedicine       Date:  2015-03-11

4.  A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders.

Authors:  Mara Perrone; Byung Seok Moon; Hyun Soo Park; Valentino Laquintana; Jae Ho Jung; Annalisa Cutrignelli; Angela Lopedota; Massimo Franco; Sang Eun Kim; Byung Chul Lee; Nunzio Denora
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

5.  TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation.

Authors:  Valentino Laquintana; Nunzio Denora; Annalisa Cutrignelli; Mara Perrone; Rosa Maria Iacobazzi; Cosimo Annese; Antonio Lopalco; Angela Assunta Lopedota; Massimo Franco
Journal:  Int J Mol Sci       Date:  2016-06-18       Impact factor: 5.923

6.  Fabrication of photoactive heterostructures based on quantum dots decorated with Au nanoparticles.

Authors:  Elisabetta Fanizza; Carmine Urso; R Maria Iacobazzi; Nicoletta Depalo; Michela Corricelli; Annamaria Panniello; Angela Agostiano; Nunzio Denora; Valentino Laquintana; Marinella Striccoli; M Lucia Curri
Journal:  Sci Technol Adv Mater       Date:  2016-04-12       Impact factor: 8.090

7.  An Updated View of Translocator Protein (TSPO).

Authors:  Nunzio Denora; Giovanni Natile
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

8.  Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes.

Authors:  Tiziana Latronico; Nicoletta Depalo; Gianpiero Valente; Elisabetta Fanizza; Valentino Laquintana; Nunzio Denora; Anna Fasano; Marinella Striccoli; Matilde Colella; Angela Agostiano; M Lucia Curri; Grazia Maria Liuzzi
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

9.  Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position.

Authors:  Salvatore Savino; Nunzio Denora; Rosa Maria Iacobazzi; Letizia Porcelli; Amalia Azzariti; Giovanni Natile; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2016-06-25       Impact factor: 5.923

10.  Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier.

Authors:  Antonio Lopalco; Annalisa Cutrignelli; Nunzio Denora; Angela Lopedota; Massimo Franco; Valentino Laquintana
Journal:  Nanomaterials (Basel)       Date:  2018-03-20       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.